Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Bio-techne Corp.
Headquarters: Minneapolis, MN, United States of America
Website: http://bio-techne.com
Year Founded: 1981
Status: Public
Industry Sector: HealthTechnology
CEO: Kim Kelderman
Number Of Employees: 3,100
Enterprise Value: $11,786,132,100
PE Ratio: 55.76
Exchange/Ticker 1: NASDAQ:TECH
Exchange/Ticker 2: N/A
Latest Market Cap: $9,229,177,856
BioCentury | Jun 1, 2024
Management Tracks
Verve promotes Lister to CSO
Plus: Quantum-Si appoints Kummeth independent chair and updates from Alkeus and SAB
BioCentury | Feb 14, 2024
Management Tracks
New CEOs for Enable, StromaCare
Plus: Philippakis joins GV as general partner, and updates from Verily, Meliora, Citryll and Silver Creek
BioCentury | Feb 24, 2023
Management Tracks
Juan Andres to retire from Moderna
Plus: Avidity promotes Flanagan, a new chair at Ansa
BioCentury | Aug 5, 2022
Management Tracks
Frank Zhang returns to Legend
Plus Protano named CFO at Alltrna, and updates from Laronde, Xentria and more
BioCentury | Jan 15, 2022
Discovery & Translation
HLA-independent TCRs with increased antigen sensitivity; plus Synthekine, Luminary and more
BioCentury’s roundup of translational news
BioCentury | Jan 8, 2022
Management Tracks
Totus recruits Singer as first CFO
Plus updates from Pharmaron, Adverum, Azenta, InterVenn and more
BioCentury | Aug 22, 2020
Emerging Company Profile
Luminary: turning cell engineering tools into therapies
Former B-MoGen execs leverage experience in non-viral cell engineering tools to form therapeutic start-up
BioCentury | Jan 25, 2020
Tools & Techniques
Manufacturing roundup: Deerfield launches new CDMO, plus a gene/cell therapy JV and more
Biotechs, academics turn to partnerships to overcome manufacturing barriers to gene and cell therapies
BioCentury | Jan 22, 2020
Company News
JV to combine technologies into one gene and cell therapy manufacturing platform
Bio-Techne, Fresenius Kabi and Wilson Wolf will create a platform to scale up manufacturing as Bellicum sells off facility to save costs
BioCentury | Apr 25, 2019
Emerging Company Profile
miR Scientific: spotting aggression with RNA in urine
How miR is developing diagnostic, prognostic cancer tests using sncRNA in urine
Items per page:
1 - 10 of 18